FGFR2 and cancer: To determine the clinical relevance of FGFR2 and FGF7 in RMS patient tumors, we analyzed gene expression data generated in the ITCC/CIT (Innovative Therapies for Children with Cancer/Carte d’Identite’ des Tumeurs) cohort [29].